\u5b66\u8853\u7d39\u4ecb\uff1a
\u524d\u7acb\u817a\u80a5\u5927\u75c7\u306b\u3088\u308b\u4e2d\u7b49\u5ea6\u304b\u3089\u91cd\u5ea6\u306e\u4e0b\u90e8\u5c3f\u8def\u75c7\u72b6\u306b\u5bfe\u3059\u308b\u6c34\u84b8\u6c17\u6e29\u71b1\u6cbb\u7642\u306e\u591a\u65bd\u8a2d\u30e9\u30f3\u30c0\u30e0\u5316\u507d\u5bfe\u7167\u6bd4\u8f03\u8a66\u9a13\u306e\u6700\u7d425\u5e74\u9593\u306e\u7d50\u679c
\u3000\u6cb3\u5408\u3000\u61b2\u5eb7*
\u3000\u540d\u53e4\u5c4b\u5e02\u7acb\u5927\u5b66\u533b\u5b66\u90e8\u9644\u5c5e\u307f\u3069\u308a\u5e02\u6c11\u75c5\u9662\u3000\u6ccc\u5c3f\u5668\u79d1<\/p>\n\n\n\n
\u524d\u7acb\u817a\u80a5\u5927\u75c7\u306e\u7f79\u60a3\u7387\u306f\u52a0\u9f62\u3068\u3068\u3082\u306b\u5897\u52a0\u3057, \u524d\u7acb\u817a\u80a5\u5927\u75c7\u306750\u6b73\u4ee5\u4e0a\u306e\u60a3\u8005\u306e50-70\uff05, 80\u6b73\u4ee3\u306e\u60a3\u8005\u306e80\uff05\u4ee5\u4e0a\u306f\u6392\u5c3f\u969c\u5bb3, \u983b\u5c3f\u306a\u3069\u306e\u4e0b\u90e8\u5c3f\u8def\u75c7\u72b6\u3092\u5448\u3059\u308b1)\uff0e\u4e2d\u7b49\u5ea6 \u304b\u3089\u91cd\u5ea6\u306e\u4e0b\u90e8\u5c3f\u8def\u75c7\u72b6\u306b\u5bfe\u3059\u308b\u6cbb\u7642\u306e\u7b2c\u4e00\u9078\u629e\u306f\u03b11\u30d6\u30ed\u30c3\u30ab\u30fc\u20201\u30845\u03b1\u9084\u5143\u9175\u7d20\u963b\u5bb3\u5264\u20202\u306e\u5185\u670d\u3067\u3042\u308b\u304c, \u3053\u308c\u3089\u306e\u5185\u670d\u306f, \u5c04\u7cbe\u969c\u5bb3\uff0c\u7cbe\u6db2\u6e1b\u5c11\u306a\u3069\u306e\u6027\u6a5f\u80fd\u3092\u969c\u5bb3\u3059\u308b\u305f\u3081\uff0c\u4ee3 \u66ff\u6cbb\u7642\u304c\u671b\u307e\u308c\u3066\u3044\u308b\uff0e\u307e\u305f, \u624b\u8853\u6cbb\u7642\u3068\u3057\u3066\u306f\u7d4c\u5c3f\u9053\u7684\u524d\u7acb\u817a\u5207\u9664\u8853(TURP\u20203)\u304c\u4f1d\u7d71\u7684\u306b\u6a19\u6e96\u624b\u8853\u3067\u3042\u3063\u305f\u304c, \u540c\u69d8\u306b\u624b\u8853\u4fb5\u8972\u3084\u8853\u5f8c\u6027\u6a5f\u80fd\u969c\u5bb3\u304c\u61f8\u5ff5\u3055\u308c\u308b\u305f\u3081\uff0c\u4ee3\u66ff\u624b\u8853\u304c\u671b\u307e \u308c\u3066\u3044\u308b\uff0eTURP\u306b\u4ee3\u308f\u308b\u4f4e\u4fb5\u8972\u624b\u8853\u624b\u6280\u3068\u3057\u3066\u6c34\u84b8\u6c17\u6e29\u71b1\u6cbb\u7642(Rezum System)\u304c\u958b\u767a\u3055\u308c\uff0c\u7c73\u56fd\u98df\u54c1\u533b\u85ac\u54c1\u5c40\u306b2015\u5e74\u306b\u8a8d\u53ef\u3055\u308c\u305f\uff0e\u4eca\u56de, \u6c34\u84b8\u6c17\u6e29\u71b1\u6cbb\u7642\u306e\u591a\u65bd\u8a2d\u30e9\u30f3\u30c0\u30e0\u5316\u507d\u5bfe\u7167\u6bd4\u8f03\u8a66\u9a13\u306e\u6700 \u7d425\u5e74\u9593\u306e\u7d50\u679c\u304c\u516c\u958b\u3055\u308c\u305f\u306e\u3067\u7d39\u4ecb\u3059\u308b2)\uff0e
\u6c34\u84b8\u6c17\u6e29\u71b1\u6cbb\u7642(Rezum System)\u306e\u539f\u7406\u3092\u6982\u8aac\u3059\u308b\uff0e103\u2103\u306e\u6c34\u84b8\u6c17\u3092\u7d4c\u5c3f\u9053\u7684\u306b\u524d\u7acb\u817a\u7d44\u7e54\u306b\u5bfe\u30579\u79d2\u9593\u5674\u9727\u3057\uff0c\u524d\u7acb\u817a\u7d44\u7e54\u3092\u7d0470\u2103\u307e\u3067\u4e0a\u6607\u3055\u305b\uff0c\u7d44\u7e54\u3092\u58ca\u6b7b\u3055\u305b\u308b\u3082\u306e\u3067\u3042\u308b\uff0e\u6c34\u84b8\u6c17\u306f540 cal\/ml\u306e\u30a8\u30cd\u30eb\u30ae\u30fc\u3092\u84c4\u7a4d\u3057\u3066\u304a \u308a\uff0c\u6c34\u84b8\u6c17\u304c\u524d\u7acb\u817a\u7d44\u7e54\u5185\u3067\u6c34\u306b\u623b\u308b\u969b\uff08\u76f8\u8ee2\u79fb\uff09\u306b\uff0c\u3053\u306e\u30a8\u30cd\u30eb\u30ae\u30fc\u304c\u77ac\u6642\u306b\u653e\u51fa\u3055\u308c\uff0c\u7d44\u7e54\u306e\u58ca\u6b7b\u306f\u3053\u306e\u30a8\u30cd\u30eb\u30ae\u30fc\u3092\u7528\u3044\u3066\u3044\u308b\uff0e\u524d\u7acb\u817a\u306e\u5916\u5074\u306f\u524d\u7acb\u817a\u7d44\u7e54\u306e\u80a5\u5927\u306b\u3088\u308a\u507d\u88ab\u819c\u304c\u5f62\u6210\u3055\u308c\u3066\u3044\u308b\u305f\u3081, \u6c34\u84b8\u6c17\u306f\u507d\u88ab\u819c\u3092\u901a\u904e \u305b\u305a\uff0c\u6cbb\u7642\u52b9\u679c\u306f\u524d\u7acb\u817a\u5185\u90e8\u306b\u9650\u5c40\u3059\u308b\u3068\u8003\u3048\u3089\u308c\u308b\uff0e\u306a\u304a\uff0c\u507d\u5bfe\u7167\u7fa4\u306f19-22Fr\u786c\u6027\u8180\u80f1\u93e1\u3092\u6cbb\u7642\u7fa4\u3068\u540c\u69d8\u306b\u524d\u7acb\u817a\u90e8\u5c3f\u9053\u307e\u3067\u633f\u5165\u3092\u884c\u3063\u305f\uff0e
2013\u5e749\u6708\u304b\u30892014\u5e748\u6708\u307e\u3067\u306b384\u540d\u304c\u30a8\u30f3\u30c8\u30ea\u30fc\u3057\uff0c\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\u306e\u7d50\u679c197\u540d\u304c\u8a66\u9a13\u306b\u53c2\u52a0\u3057\u305f\uff0e\u9069\u5fdc\u57fa\u6e96\u306f50\u6b73\u4ee5\u4e0a\uff0cIPSS\u20204>13\uff0c\u524d\u7acb\u817a\u4f53\u7a4d\u304c30\uff5e80 cm3\uff0c\u4e2d\u8449\u80a5\u5927\u20205\u304c\u306a\u3044\u3053\u3068\u3067\u3042\u308b\uff0e\u6cbb\u7642\u7fa4\u3068\u507d \u5bfe\u7167\u7fa4\u30922:1\u306b\u30e9\u30f3\u30c0\u30e0\u306b\u5206\u3051, 135\u540d\u304c\u6cbb\u7642\u7fa4\uff0c61\u540d\u304c\u507d\u5bfe\u7167\u7fa4\u3068\u306a\u3063\u305f\uff0e\u507d\u5bfe\u7167\u7fa461\u540d\u4e2d53\u540d\u304c\u8a66\u9a13\u958b\u59cb3\u30f6\u6708\u5f8c\u306b\u30af\u30ed\u30b9\u30aa\u30fc\u30d0\u30fc\u3068\u3057\u3066Rezum\u6cbb\u7642\u3092\u53d7\u3051\u305f\uff0e
\u6cbb\u7642\u52b9\u679c\u5224\u5b9a\u306b\u306f\u2460IPSS\u20204 \u2461IPSS QOL\u20205 \u2462Qmax\u20206 \u2463BPHII\u20207\u3092\u7528\u3044\u305f\uff0e\u307e\u305f\u89b3\u5bdf\u671f\u95935\u5e74\u9593\u306b\u304a\u3051\u308b\u518d\u624b\u8853\u306e\u983b\u5ea6\u3082\u691c\u8a3c\u3057\u305f\uff0e\u6cbb\u7642\u7fa4\u3067\u306fIPSS\u306f, \u6cbb\u7642\u304b\u30893\u30f6\u6708\u306722.0\u304b\u308910.6\u3078\u4e0b\u964d\u3057\uff0c5\u5e74\u9593\u4f4e\u5024 \u3092\u7dad\u6301\u3057\u305f\uff0eIPSS QOL\u3082\u540c\u69d8\u306b, \u6cbb\u7642\u304b\u30893\u30f6\u6708\u30674.4\u00b11.1\u304b\u30892.3\u00b11.5\u3078\u4e0b\u964d\u3057\uff0c\u3055\u3089\u306b\u6cbb\u7642\u304b\u30895\u5e74\u5f8c\u306b2.2\u00b11.4\u3078\u4e0b\u964d\u3057\u305f\uff0eQmax\u306f, \u6cbb\u7642\u304b\u30893\u30f6\u6708\u30679.9\u00b12.2 ml\/\u79d2\u304b\u308915.5\u00b16.7 ml\/\u79d2\u3078\u4e0a\u6607 \u3057\uff0c5\u5e74\u9593\u7dad\u6301\u3057\u305f\uff0eBPHII\u3082\u540c\u69d8\u306b\u8853\u5f8c\u534a\u5e74\u306751%\u6e1b\u5c11\u3057\uff0c5\u5e74\u5f8c\u3067\u306f\u6700\u5927\u5024\u306e45%\u3067\u7dad\u6301\u3057\u3066\u3044\u305f\uff0e5\u5e74\u9593\u3067\u6c34\u84b8\u6c17\u624b\u8853\u3084\u30ec\u30fc\u30b6\u30fc\u6838\u51fa\u8853\u306a\u3069\u306e\u518d\u624b\u8853\u3068\u306a\u3063\u305f\u75c7\u4f8b\u306f5%\u672a\u6e80\u3067\u3042\u3063\u305f\uff0e\u307e\u305f\uff0c\u30af\u30ed\u30b9\u30aa\u30fc\u30d0\u30fc\u30673\u30f6\u6708\u5f8c\u306bRezum\u3092\u65bd\u884c\u3057\u305f\u7fa4\u3082\u540c\u69d8\u306e\u7d50\u679c\u3092\u793a\u3057\u305f\uff0e
\u3000\u6709\u5bb3\u4e8b\u8c61\u306f\u6cbb\u7642\u7fa4\u3068\u507d\u5bfe\u7167\u7fa4\u3067\uff0c\u8853\u5f8c\u306e\u6392\u5c3f\u56f0\u96e316.9%:18.9%\uff0c\u8840\u5c3f12.5%\uff1a1.3%\uff0c\u8840\u7cbe\u6db2\u75c7\u202087.4%\uff1a3.8%\uff0c\u983b\u5c3f5.9%\uff1a5.7%\uff0c\u5c3f\u95894.4%\uff1a5.7%\uff0c\u5c3f\u8def\u611f\u67d3\u75c73.7%\uff1a7.5%\uff0c\u7cbe\u6db2\u91cf\u6e1b\u5c113.7%\uff1a7.5%\u3068\u5dee\u306f\u8a8d\u3081\u306a\u304b\u3063\u305f\uff0e
\u3000\u4ed6\u306e\u4f4e\u4fb5\u8972\u624b\u8853\u624b\u6280\u306b\u306f\u7d4c\u5c3f\u9053\u7684\u524d\u7acb\u817a\u3064\u308a\u4e0a\u3052\u8853\u304c\u3042\u308b\uff0e\u3057\u304b\u3057\uff0c\u3053\u308c\u306f\u30a4\u30f3\u30d7\u30e9\u30f3\u30c8\u3067\u524d\u7acb\u817a\u7d44\u7e54\u3092\u3064\u308a\u4e0a\u3052\u3066\u5c3f\u9053\u3092\u5e83\u3052\u308b\u624b\u8853\u3067\u3042\u308a\uff0c\u524d\u7acb\u817a\u7d44\u7e54\u306f\u6458\u9664\u3057\u306a\u3044\uff0e\u3053\u306e\u305f\u30815\u5e74\u9593\u306e\u518d\u624b\u8853\u7387\u306f13.6%\u3067\u3042\u308b3)\uff0e\u307e\u305f\uff0c\u6e29\u71b1\u6cbb\u7642\u3092\u5229\u7528\u3057\u305f\u7d4c\u5c3f\u9053\u7684\u624b\u8853\u624b\u6280\u3068\u3057\u3066\u7d4c\u5c3f\u9053\u7684\u91dd\u713c\u707c\u8853(TUNA\u20209)4)\uff0c\u7d4c\u5c3f\u9053\u7684\u30de\u30a4\u30af\u30ed\u6ce2\u9ad8\u6e29\u5ea6\u6cbb\u7642\u8853(TUMT\u202010)5)\u3082\u3042\u308b\u304c\uff0c5\u5e74\u9593\u306e\u518d\u624b\u8853\u7387\u306f\u305d\u308c\u305e\u308c\u7d0450%\uff0c20%\u3068\u9ad8\u7387\u3067\u3042\u308b\uff0e
\u5b89\u5168\u6027\uff0c\u6027\u6a5f\u80fd\u306e\u7dad\u6301,\u305d\u3057\u3066\u7279\u306b\u9577\u671f\u9593\u306e\u52b9\u679c\u306e\u6301\u7d9a\u3068\u3044\u3046\u89b3\u70b9\u304b\u3089\u524d\u7acb\u817a\u80a5\u5927\u75c7\u306b\u3088\u308b\u4e2d\u7b49\u5ea6\u304b\u3089\u91cd\u5ea6\u306e\u4e0b\u90e8\u5c3f\u8def\u75c7\u72b6\u306b\u5bfe\u3059\u308b\u6c34\u84b8\u6c17\u6e29\u71b1\u6cbb\u7642\u306f\u9078\u629e\u80a2\u306e\u4e00\u3064\u3068\u8003\u3048\u3089\u308c,\u672c\u90a6\u3067\u3082\u65bd\u884c\u3055\u308c\u308b\u75c7\u4f8b\u304c\u5897\u3048\u3066\u3044\u308b.
\u53c2\u8003\u6587\u732e
1) Egan K.B.: The epidemiology of benign prostatic hyperplasia associated with lower urinary tract symptoms: prevalence and incident rates. Urol Clin North Am, 43: 289-297, 2016.
2) McVary K.T., Gittelman M.C., Goldberg K.A., Patel K., Shore N.D., Levin R.M., Pliskin M., Beahrs J.R., Prall D., Kaminetsky J., Cowan B.E., Cantrill C.H., Mynderse L.A., Ulchaker J.C., Tadros N.N., Gange S.N., Roehrborn C.G.: Final 5-Year outcomes of the multicenter randomized sham-controlled trial of a water vapor thermal therapy for treatment of moderate to severe lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol, 206:715-724,2021.
3) Roehrborn C.G., Barkin J., Gange S.N., Shore N.D., Giddens J.L., Bolton D.M., Cowan B.E., Cantwell A.L., McVary K.T., Te A.E., Gholami S.S., Moseley W.G., Chin P.T., Dowling W.T., Freedman S.J., Incze P.F., Coffield K.S., Herron S., Rashid P., Rukstalis D.B.: Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study. Can J Urol, 24: 8802-8813, 2017.
4) Hill B., Belville W., Bruskewitz R., Issa M., Perez-Marrero R., Roehrborn C., Terris M., Naslund M.: Transurethral needle ablation versus transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia: 5-year results of a prospective, randomized, multicenter clinical trial. J Urol, 171: 2336-2340, 2004.
5) Mynderse L.A., Roehrborn C.G., Partin A.W., Preminger G.M., Cot\u00e9 E.P.: Results of a 5-year multicenter trial of a new generation cooled high energy transurethral microwave thermal therapy catheter for benign prostatic hyperplasia. J Urol, 185:1804-1810, 2011.
\u7528\u8a9e\u89e3\u8aac
\u26281\u03b11\u30d6\u30ed\u30c3\u30ab\u30fc\uff1a \u524d\u7acb\u817a\u306f\u4ea4\u611f\u795e\u7d4c\u53d7\u5bb9\u4f53\u304c\u8c4a\u5bcc\u306b\u5b58\u5728\u3057\uff0c\u03b1\u4ea4\u611f\u795e\u7d4c\u523a\u6fc0\u3067\u524d\u7acb\u817a\u304c\u53ce\u7e2e\u3057\u6392\u5c3f\u969c\u5bb3\u3092\u8d77\u3053\u3059\uff0e\u03b1\u30d6\u30ed\u30c3\u30ab\u30fc\u306b\u3088\u308a\u524d\u7acb\u817a\u306e\u53ce\u7e2e\u3092\u6291\u3048\u62b5\u6297\u3092\u3068\u308a\u6392\u5c3f\u6539\u5584\u3092\u76ee\u6307\u3059\u85ac\u5264\uff0e
\u26282 5\u03b1\u9084\u5143\u9175\u7d20\u963b\u5bb3\u5264\uff1a \u524d\u7acb\u817a\u306f\u30c6\u30b9\u30c8\u30b9\u30c6\u30ed\u30f3\u304c5\u03b1\u9084\u5143\u9175\u7d20\u306b\u3088\u308a\u5909\u63db\u3055\u308c\u305f\u30b8\u30d2\u30c9\u30ed\u30c6\u30b9\u30c8\u30b9\u30c6\u30ed\u30f3\u304c\u4f5c\u7528\u3057\u3066\u816b\u5927\u3059\u308b\uff0e5\u03b1\u9084\u5143\u9175\u7d20\u963b\u5bb3\u5264\u306b\u3088\u308a\u30b8\u30d2\u30c9\u30ed\u30c6\u30b9\u30c8\u30b9\u30c6\u30ed\u30f3\u306e\u6fc3\u5ea6\u3092\u4f4e\u4e0b\u3055\u305b\uff0c\u524d\u7acb\u817a\u306e\u816b\u5927\u3092\u6291\u5236\u3059\u308b\uff0e
\u26283 TURP: Transurethral Resection of Prostate\uff0e\u7d4c\u5c3f\u9053\u7684\u524d\u7acb\u817a\u5207\u9664\u8853\uff0e\u5185\u8996\u93e1\u3092\u7528\u3044\u7d4c\u5c3f\u9053\u7684\u306b\u524d\u7acb\u817a\u306e\u817a\u816b\u3092\u96fb\u6c17\u30e1\u30b9\u3067\u5207\u9664\u3059\u308b\uff0e\u51fa\u8840\u3084\u6027\u6a5f\u80fd\u969c\u5bb3\u306a\u3069\u306e\u6709\u5bb3\u4e8b\u8c61\u304c\u591a\u3044\uff0e
\u26284 IPSS\uff1aInternational Prostate Symptom Score\uff0e\u56fd\u969b\u524d\u7acb\u817a\u75c7\u72b6\u30b9\u30b3\u30a2\uff0e\u524d\u7acb\u817a\u80a5\u5927\u75c7\u306b\u5bfe\u3059\u308b\u75c7\u72b6\u8cea\u554f\u8868\u3067\u3042\u308a\uff0c\u70b9\u6570\u304c\u9ad8\u3044\u65b9\u304c\u91cd\u75c7. \u6b8b\u5c3f\u611f\uff0c\u983b\u5c3f\uff0c\u5c3f\u7dda\u9014\u7d76\uff0c\u5c3f\u610f\u5207\u8feb\u611f\uff0c\u5c3f\u52e2\u4f4e\u4e0b\uff0c\u8179\u5727 \u6392\u5c3f\uff0c\u591c\u9593\u6392\u5c3f\u56de\u6570\u306e7\u9805\u76ee\u306e\u8cea\u554f\u304b\u3089\u6210\u308a\uff0c\u305d\u308c\u305e\u308c0\u301c5\u70b9\u306e\u70b9\u6570\u3092\u3064\u3051\u308b\uff0e\u5408\u8a08\u70b9\u6570\u304c0\u301c7\u70b9\uff0c8\u301c19\u70b9\uff0c20\u301c35\u70b9\u3092\u305d\u308c\u305e\u308c\u8efd\u75c7\uff0c\u4e2d\u7b49\u75c7\uff0c\u91cd\u75c7\u3068\u8a55\u4fa1\u3059\u308b\uff0e\u307e\u305f\uff0cQOL\u30b9\u30b3\u30a2\u306f\u73fe\u5728\u306e\u6392\u5c3f\u72b6\u614b\u306b\u5bfe\u3059\u308b\u60a3\u8005\u81ea\u8eab\u306e\u6e80\u8db3\u5ea6\u3092\u793a\u3059\u6307\u6a19\u3067\uff0c0\u70b9\uff08\u3068\u3066\u3082\u6e80\u8db3\uff09\u304b\u30896\u70b9\uff08\u3068\u3066\u3082\u3044\u3084\u3060\uff09\u307e\u3067\u306e7\u6bb5\u968e\u3067\u8a55\u4fa1\u3057\uff0c\u8efd\u75c7\uff080\u301c1\u70b9\uff09\uff0c\u4e2d\u7b49\u75c7\uff082\u301c4\u70b9\uff09\uff0c\u91cd\u75c7\uff085\u301c6\u70b9\uff09\u306b\u5206\u985e\u3059\u308b\uff0e
\u26285 IPSS QOL: \u73fe\u5728\u306e\u6392\u5c3f\u306b\u95a2\u3059\u308b\u60a3\u8005\u306e\u6e80\u8db3\u5ea6\u3092\u793a\u3059\u6307\u6a19.\u300c\u73fe\u5728\u306e\u5c3f\u306e\u72b6\u614b\u304c\u3053\u306e\u307e\u307e\u7d9a\u3044\u305f\u3089\u3069\u3046\u601d\u3046\u304b\u300d\u3068\u3044\u3046\u8cea\u554f\uff0c0\u70b9\uff08\u3068\u3066\u3082\u6e80\u8db3\uff09\u304b\u30896\u70b9\uff08\u3068\u3066\u3082\u3044\u3084\u3060\uff09\u3067\u6e80\u8db3\u5ea6\u3092\u8a55\u4fa1\u3059\u308b\uff0e
\u26286 Qmax: \u5358\u4f4d\u6642\u9593\u3042\u305f\u308a\u306e\u6392\u5c3f\u91cf\u3092\u6e2c\u5b9a\u3059\u308b\u3068\u304d\u306e\u6700\u5927\u306e\u5024\uff0e20 ml\/\u79d2\u304c\u5c3f\u52e2\u6e1b\u5f31\u306e\u76ee\u5b89\u3068\u306a\u3063\u3066\u3044\u308b\uff0e\u6570\u5024\u304c\u5927\u304d\u3044\u65b9\u304c\u5c3f\u52e2\u304c\u826f\u3044\u3053\u3068\u3092\u793a\u3059.
\u26287 BPHII: Benign Prostatic Hyperplasia Impact Index\uff0e\u524d\u7acb\u817a\u80a5\u5927\u75c7\u306e\u81ea\u899a\u75c7\u72b6\u3092\u8a55\u4fa1\u3057\uff0c\u91cd\u75c7\u5ea6\u3092\u5224\u5b9a\u3059\u308b\u305f\u3081\u306e\u8cea\u554f\u7968\u306e\u4e00\u3064\uff0e\u8eab\u4f53\u306e\u4e0d\u5b89\u3084\u7169\u308f\u3057\u3055\u3092\u8a55\u4fa1\u3059\u308b\u3082\u306e\u3067\uff0c0\u301c10\u70b9\u3067\u8a55\u4fa1\u3055\u308c,\u70b9\u6570\u304c\u9ad8\u3044\u65b9\u304c\uff0c\u4e0d\u6e80\u304c\u5927\u304d\u3044\u3053\u3068\u3092\u793a\u3059.
\u26288\u8840\u7cbe\u6db2\u75c7: \u7cbe\u6db2\u306b\u8840\u6db2\u304c\u6df7\u5165\u3057,\u7cbe\u6db2\u304c\u8d64\u8272\u8abf\u3092\u793a\u3059\u72b6\u614b\u306e\u3053\u3068. \u51fa\u8840\u90e8\u4f4d\u3068\u3057\u3066\u306f\u591a\u304f\u306e\u5834\u5408\u7cbe\u56a2\u307e\u305f\u306f\u524d\u7acb\u817a.
\u26289TUNA: Transurethral Needle Ablation\uff0e\u7d4c\u5c3f\u9053\u7684\u91dd\u713c\u707c\u8853\uff0e\u91dd\u96fb\u6975\u3092\u524d\u7acb\u817a\u306b\u523a\u5165\u3057\uff0c\u30e9\u30b8\u30aa\u6ce2\u3067\u52a0\u6e29\u3059\u308b\uff0e
\u262810TUMT: Transurethral Microwave Thermotherapy\uff0e\u7d4c\u5c3f\u9053\u7684\u30de\u30a4\u30af\u30ed\u6ce2\u9ad8\u6e29\u5ea6\u6cbb\u7642\uff0e\u7d4c\u5c3f\u9053\u30d7\u30ed\u30fc\u30d6\u3067\u30de\u30a4\u30af\u30ed\u6ce2\u3092\u7528\u3044\u3066\u524d\u7acb\u817a\u3092\u52a0\u6e29\uff0e
\u5229\u76ca\u76f8\u53cd\u306b\u95a2\u3059\u308b\u958b\u793a\uff1a
\u3000\u8457\u8005\u306b\u5229\u76ca\u76f8\u53cd\u72b6\u614b\u306f\u8a8d\u3081\u3089\u308c\u306a\u304b\u3063\u305f\uff0e<\/p>\n\n\n\n
Mini-review:
Water Vapor Thermal Therapy for Benign Prostate Hyperplasia
NORIYASU KAWAI*
Department of Urology, Nagoya City University Midori Municipal Hospital
Nagoya 458-0037, Japan.
*Corresponding author: n-kawai@med.nagoya-cu.ac.jp
Key Words: water vapor thermal therapy, benign prostate hyperplasia, clinical trial
Received: 15 June, 2023
Accepted: 31 July, 2023<\/p>\n\n\n\n
Thernal medicine Vol.39(3)\u63b2\u8f09\u4e88\u5b9a<\/p>\n\n\n\n
\u4e00\u822c\u793e\u56e3\u6cd5\u4eba\u65e5\u672c\u30cf\u30a4\u30d1\u30fc\u30b5\u30fc\u30df\u30a2\u5b66\u4f1a\u4e8b\u52d9\u5c40
\u3012630-8105\u3000\u5948\u826f\u770c\u5948\u826f\u5e02\u4f50\u4fdd\u53f03\u4e01\u76ee902-58
Tel, 0742-93-6360; Fax, 0742-93-6361;
e-mail, jsho@jsho.jp<\/p>\n\n\n\n
\u5b66\u8853\u7d39\u4ecb\uff1a\u524d\u7acb\u817a\u80a5\u5927\u75c7\u306b\u3088\u308b\u4e2d\u7b49\u5ea6\u304b\u3089\u91cd\u5ea6\u306e\u4e0b\u90e8\u5c3f\u8def\u75c7\u72b6\u306b\u5bfe\u3059\u308b\u6c34\u84b8\u6c17\u6e29\u71b1\u6cbb\u7642\u306e\u591a\u65bd\u8a2d\u30e9\u30f3\u30c0\u30e0\u5316\u507d\u5bfe\u7167\u6bd4\u8f03\u8a66\u9a13\u306e\u6700\u7d425\u5e74\u9593\u306e\u7d50\u679c\u3000\u6cb3\u5408\u3000\u61b2\u5eb7*\u3000\u540d\u53e4\u5c4b\u5e02\u7acb\u5927\u5b66\u533b\u5b66\u90e8\u9644\u5c5e\u307f\u3069\u308a\u5e02\u6c11\u75c5\u9662\u3000\u6ccc\u5c3f\u5668\u79d1 \u524d\u7acb\u817a\u80a5\u5927\u75c7\u306e\u7f79\u60a3\u7387\u306f\u52a0\u9f62 […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"vkexunit_cta_each_option":"","footnotes":""},"categories":[2],"tags":[],"class_list":["post-2339","post","type-post","status-publish","format-standard","hentry","category-newsletter"],"_links":{"self":[{"href":"https:\/\/idsc-gunma.jp\/congress\/jstm\/wp-json\/wp\/v2\/posts\/2339","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idsc-gunma.jp\/congress\/jstm\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idsc-gunma.jp\/congress\/jstm\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idsc-gunma.jp\/congress\/jstm\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/idsc-gunma.jp\/congress\/jstm\/wp-json\/wp\/v2\/comments?post=2339"}],"version-history":[{"count":1,"href":"https:\/\/idsc-gunma.jp\/congress\/jstm\/wp-json\/wp\/v2\/posts\/2339\/revisions"}],"predecessor-version":[{"id":2340,"href":"https:\/\/idsc-gunma.jp\/congress\/jstm\/wp-json\/wp\/v2\/posts\/2339\/revisions\/2340"}],"wp:attachment":[{"href":"https:\/\/idsc-gunma.jp\/congress\/jstm\/wp-json\/wp\/v2\/media?parent=2339"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idsc-gunma.jp\/congress\/jstm\/wp-json\/wp\/v2\/categories?post=2339"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idsc-gunma.jp\/congress\/jstm\/wp-json\/wp\/v2\/tags?post=2339"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}